Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome.
Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Making myelin basic protein -from mRNA transport to localized translation.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration.
Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
Modulation of C-nociceptive Activities by Inputs from Myelinated Fibers.
Environmental Enrichment Stimulates Immune Cell Secretion of Exosomes that Promote CNS Myelination and May Regulate Inflammation.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid.
Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice.
Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis.
Molecular Architecture of Myelinated Nerve Fibers: Leaky Paranodal Junctions and Paranodal Dysmyelination.
Magnetic resonance frequency shifts during acute MS lesion formation.
A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic.
Pages
« first
‹ previous
…
669
670
671
672
673
674
675
676
677
…
next ›
last »